Nora Schmidt-Kesseler

Nora Schmidt-Kesseler is not mentioned in either of the provided news articles. The articles primarily focus on the German chemical industry's concerns regarding political risks associated with upcoming elections in Eastern Germany, potential impacts of US tariffs on the pharmaceutical industry, growing opportunities in the defense sector, and updates on Eli Lilly's weight-loss drug approval. Therefore, it's impossible to provide any information about Nora Schmidt-Kesseler's background, newsworthiness, recent events, or relevance based on the given context. The articles do not contain any information about this individual.